Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus

INTRODUCTION: Acute and chronic insomnia can exacerbate type 2 diabetes mellitus (T2DM). We investigated suvorexant (an anti-insomnia drug that targets the orexin system) effects on sleep architecture and glucose metabolism in T2DM patients with insomnia. MATERIALS AND METHODS: This 7 day open-label...

Descripción completa

Detalles Bibliográficos
Autores principales: Toi, Norikazu, Inaba, Masaaki, Kurajoh, Masafumi, Morioka, Tomoaki, Hayashi, Noriyuki, Hirota, Tomoe, Miyaoka, Daichi, Emoto, Masanori, Yamada, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306692/
https://www.ncbi.nlm.nih.gov/pubmed/30619717
http://dx.doi.org/10.1016/j.jcte.2018.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306692/
https://www.ncbi.nlm.nih.gov/pubmed/30619717
http://dx.doi.org/10.1016/j.jcte.2018.12.006

Ejemplares similares